Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial.
Benziger CP, Stebbins A, Wruck LM, Effron MB, Marquis-Gravel G, Farrehi PM, Girotra S, Gupta K, Kripalani S, Munoz D, Polonsky TS, Sharlow A, Whittle J, Harrington RA, Rothman RL, Hernandez AF, Jones WS.
Benziger CP, et al. Among authors: marquis gravel g.
JAMA Cardiol. 2024 Sep 1;9(9):808-816. doi: 10.1001/jamacardio.2024.1712.
JAMA Cardiol. 2024.
PMID: 38985488
Clinical Trial.